VASCULAR ANOMALIES
Clinical trials for VASCULAR ANOMALIES explained in plain language.
Never miss a new study
Get alerted when new VASCULAR ANOMALIES trials appear
Sign up with your email to follow new studies for VASCULAR ANOMALIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cancer drug shows promise for rare vascular conditions in kids and young adults
Disease control OngoingThis study tests the drug alpelisib (already approved for some breast cancers) in people aged 2 months to 30 years with rare blood vessel growth disorders caused by specific gene changes. Participants take the drug for at least 2 years, and researchers measure improvement using s…
Matched conditions: VASCULAR ANOMALIES
Phase: PHASE2 • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated May 11, 2026 20:54 UTC
-
Cancer drug shows promise for rare blood vessel disorders in kids
Disease control OngoingThis study tests the drug trametinib, already approved for melanoma, in people aged 2 months to 30 years with rare blood vessel growth problems caused by a specific gene pathway. The goal is to see if the drug can shrink abnormal vessels and improve quality of life. Participants …
Matched conditions: VASCULAR ANOMALIES
Phase: PHASE2 • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated May 11, 2026 20:39 UTC